Related references
Note: Only part of the references are listed.Feasibility of Axillary Lymph Node Localization and Excision Using Radar Reflector Localization
James Sun et al.
CLINICAL BREAST CANCER (2021)
Different strategies in marking axillary lymph nodes in breast cancer patients undergoing neoadjuvant medical treatment: a systematic review
Vivian Man et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
Advantages of preoperative localization and surgical resection of metastatic axillary lymph nodes using magnetic seeds after neoadjuvant chemotherapy in breast cancer
Antonio Mariscal Martinez et al.
SURGICAL ONCOLOGY-OXFORD (2021)
A comparison of two non-radioactive alternatives to wire for the localization of non-palpable breast cancers
Minna K. Lee et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Node-Positive Patients Treated with Neoadjuvant Chemotherapy Can Be Spared Axillary Lymph Node Dissection with Wireless Non-Radioactive Localizers
Alison Laws et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Prognostic Significance of Residual Axillary Nodal Micrometastases and Isolated Tumor Cells After Neoadjuvant Chemotherapy for Breast Cancer
Stephanie M. Wong et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
G. von Minckwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Targeted axillary dissection in breast cancer by marking lymph node metastasis with a magnetic seed before starting neoadjuvant treatment
Joaquin Luis Garcia-Moreno et al.
JOURNAL OF SURGICAL CASE REPORTS (2019)
Neoadjuvant Chemotherapy Use in Breast Cancer is Greatest in Excellent Responders: Triple-Negative and HER2+Subtypes
Brittany L. Murphy et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
N. Masuda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Axillary Nodal Management Following Neoadjuvant Chemotherapy A Review
Melissa Pilewskie et al.
JAMA ONCOLOGY (2017)
Localizing the Clipped Node in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Early Learning Experience and Challenges
Toan T. Nguyen et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance)
Judy C. Boughey et al.
ANNALS OF SURGERY (2016)
How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study
Anita Mamtani et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes
Emilia J. Diego et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection
Abigail S. Caudle et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Marking Axillary Lymph Nodes With Radioactive Iodine Seeds for Axillary Staging After Neoadjuvant Systemic Treatment in Breast Cancer Patients The MARI Procedure
Mila Donker et al.
ANNALS OF SURGERY (2015)
Improving the Accuracy of Axillary Lymph Node Surgery in Breast Cancer with Ultrasound-Guided Wire Localization of Biopsy Proven Metastatic Lymph Nodes
Donna Plecha et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study
Jean-Francois Boileau et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Selective Surgical Localization of Axillary Lymph Nodes Containing Metastases in Patients With Breast Cancer A Prospective Feasibility Trial
Abigail S. Caudle et al.
JAMA SURGERY (2015)
Initial Results with Preoperative Tattooing of Biopsied Axillary Lymph Nodes and Correlation to Sentinel Lymph Nodes in Breast Cancer Patients
Nicole Choy et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Tumor Biology Correlates With Rates of Breast-Conserving Surgery and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer Findings From the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial
Judy C. Boughey et al.
ANNALS OF SURGERY (2014)
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
Patricia Cortazar et al.
LANCET (2014)
Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer The ACOSOG Z1071 (Alliance) Clinical Trial
Judy C. Boughey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study
Thorsten Kuehn et al.
LANCET ONCOLOGY (2013)
Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27
Eleftherios P. Mamounas et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Share Paper
